Search research articles
Contact Us
Filters
Showing results (211-220 of 231) with videos related to
Page
of 24
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
December 17, 2020
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial
John P Hanrahan, Ian H de Boer, George L Bakris, et al.
The American Journal of Gastroenterology
|
September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation
Satish Rao, Anthony J Lembo, Steven J Shiff, et al.
The New England Journal of Medicine
|
August 12, 2011
Two randomized trials of linaclotide for chronic constipation
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Journal of Medicinal Chemistry
|
May 23, 1998
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)
D W Hansen, K B Peterson, M Trivedi, et al.
Science (New York, N.Y.)
|
January 30, 1970
Laser ranging retro-reflector: continuing measurements and expected results
C O Alley, R F Chang, D G Currie, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection
Caitlin E Edwards, Boyd L Yount, Rachel L Graham, et al.
Journal of Neuroinflammation
|
September 19, 2021
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
Susana S Correia, Guang Liu, Sarah Jacobson, et al.
Journal of Medicinal Chemistry
|
January 23, 1998
Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms
R K Webber, S Metz, W M Moore, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
February 10, 2000
Specific inhibitors of inducible nitric oxide synthase: efficacy in a rodent model of sepsis
D J Fretland, D L Widomski, C P Anglin, et al.
Diabetologia
|
December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
John P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 231) with videos related to
Sort By:
Page
of 24
Clinical Journal of the American Society of Nephrology : CJASN
|
December 17, 2020
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial
John P Hanrahan, Ian H de Boer, George L Bakris, et al.
The American Journal of Gastroenterology
|
September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation
Satish Rao, Anthony J Lembo, Steven J Shiff, et al.
The New England Journal of Medicine
|
August 12, 2011
Two randomized trials of linaclotide for chronic constipation
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, et al.
Journal of Medicinal Chemistry
|
May 23, 1998
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)
D W Hansen, K B Peterson, M Trivedi, et al.
Science (New York, N.Y.)
|
January 30, 1970
Laser ranging retro-reflector: continuing measurements and expected results
C O Alley, R F Chang, D G Currie, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection
Caitlin E Edwards, Boyd L Yount, Rachel L Graham, et al.
Journal of Neuroinflammation
|
September 19, 2021
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
Susana S Correia, Guang Liu, Sarah Jacobson, et al.
Journal of Medicinal Chemistry
|
January 23, 1998
Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms
R K Webber, S Metz, W M Moore, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
February 10, 2000
Specific inhibitors of inducible nitric oxide synthase: efficacy in a rodent model of sepsis
D J Fretland, D L Widomski, C P Anglin, et al.
Diabetologia
|
December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
John P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
Page
of 24